Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 2, 2006, Pages 312-315

  Carminati, Giuliana Galli ^a   Deriaz, Nicolas ^a   Bertschy, Gilles ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Autism; Pervasive developmental disorder; Self injurious behavior; Venlafaxine

Indexed keywords

CLONAZEPAM; FLUOXETINE; LEVOMEPROMAZINE; LEVOTHYROXINE; OLANZAPINE; PIPAMPERONE; RISPERIDONE; THIORIDAZINE; VALPROIC ACID; VENLAFAXINE; ZUCLOPENTHIXOL;

ADOLESCENT; ADULT; AGGRESSION; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; AUTOMUTILATION; BEHAVIOR; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MALE; PSYCHIATRIC DIAGNOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CYCLOHEXANOLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; SELF-INJURIOUS BEHAVIOR; TIME FACTORS;

EID: 33344472157     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.10.002     Document Type: Article

References (23)

1. A.H. Abdelmawla, R.W. Langley, E. Szabadi, and C.M. Bradshaw Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein Br. J. Clin. Pharmacol. 48 1999 345 354
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-IV fourth ed. 1994 American Psychiatric Association Washington D.C.
3. M.K. Belmonte, E.H. Cook Jr., G.M. Anderson, J.L. Rubenstein, W.T. Greenough, A. Beckel-Mitchener, E. Courchesne, L.M. Boulanger, S.B. Powell, P.R. Levitt, E.K. Perry, Y.H. Jiang, T.M. DeLorey, and E. Tierney Autism as a disorder of neural information processing: directions for research and targets for therapy (1) Mol. Psychiatry 9 2004 646 663
4. D.C. Chugani Role of altered brain serotonin mechanisms in autism Mol. Psychiatry 7 Suppl. 2 2002 S16 S17
5. I.L. Cohen, X. Liu, C. Schutz, B.N. White, E.C. Jenkins, W.T. Brown, and J.J. Holden Association of autism severity with a monoamine oxidase. A functional polymorphism Clin. Genet. 64 2003 190 197
6. E.H. Cook Jr., R. Rowlett, C. Jaselskis, and B.L. Leventhal Fluoxetine treatment of children and adults with autistic disorder and mental retardation J. Am. Acad. Child Adolesc. Psych. 31 1992 739 745
7. P.A. Davanzo, T.R. Belin, M.H. Widawski, and B.H. King Paroxetine treatment of aggression and self-injury in persons with mental retardation Am. J. Ment. Retard. 102 1998 427 437
8. V.L. Ellingrod, and P.J. Perry Venlafaxine: a heterocyclic antidepressant Am. J. Hosp. Pharm. 51 1994 3033 3046
9. C. Gillberg, and L. Svennerholm CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood Br. J. Psychiatry 151 1987 89 94
10. Guy W. CGI (Clinical Global Impression) (www.lundbeck.com/cnsforum ) ECDEU Assessment Manual for Psychopharmacology - Revised (DHEW Publ No ADM 76-338). Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research, 218-222, 1976.
11. A.T. Harvey, R.L. Rudolph, and S.H. Preskorn Evidence of the dual mechanisms of action of venlafaxine Arch. Gen. Psychiatry 57 2000 503 509
12. J.A. Hellings, L.A. Kelley, W.F. Gabrielli, E. Kilgore, and P. Shah Sertraline response in adults with mental retardation and autistic disorder J. Clin. Psychiatry 57 1996 333 336
13. E. Hollander, A. Kaplan, C. Cartwright, and D. Reichman Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report J. Child Neurol. 15 2000 132 135
14. C. Lord, M. Rutter, and A. Le Couteur Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders J. Autism Dev. Disord. 24 5 1994 659 685
15. J.K. Luiselli, P. Blew, and S. Thibadeau Therapeutic effects and long-term efficacy of antidepressant medication for persons with developmental disabilities. Behavioral assessment in two cases of treatment-resistant aggression and self-injury Behav. Modif. 25 2001 62 78
16. C.J. McDougle, L.H. Price, and W.K. Goodman Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case report J. Autism Dev. Disord. 20 1990 537 543
17. C.J. McDougle, S.T. Naylor, D.J. Cohen, F.R. Volkmar, G.R. Heninger, and L.H. Price A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder Arch. Gen. Psychiatry 53 1996 1001 1008
18. C.J. McDougle, L.F. Kresch, and D.J. Posey Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors J. Autism Dev. Disord. 30 5 2000 425 433
19. W.A. Morton, S.C. Sonne, and M.A. Verga Venlafaxine: a structurally unique and novel antidepressant Ann. Pharmacother. 29 1995 387 395
20. L.B. Namerow, P. Thomas, J.Q. Bostic, J. Prince, and M.C. Monuteaux Use of citalopram in pervasive developmental disorders J. Dev. Behav. Pediatr. 24 2003 104 108
21. M.F. Piacentini, R. Clinckers, R. Meeusen, S. Sarre, G. Ebinger, and Y. Michotte Effects of venlafaxine on extracellular 5-HT, dopamine and noradrenaline in the hippocampus and on peripheral hormone concentrations in the rat in vivo Life Sci. 73 2003 2433 2442
22. S.R. Schroeder, M.L. Oster-Granite, G. Berkson, J.W. Bodfish, G.R. Breese, M.F. Cataldo, E.H. Cook, L.S. Crnic, I. DeLeon, W. Fisher, J.C. Harris, R.H. Horner, B. Iwata, H.A. Jinnah, B.H. King, J.M. Lauder, M.H. Lewis, K. Newel, W.L. Nyhan, J. Rojahn, G.P. Sackett, C. Sandman, F. Symons, R.E. Tessel, T. Thompson, and D.F. Wong Self-injurious behavior: gene-brain-behavior relationships Ment. Retard. Dev. Disabil. Res. Rev. 7 2001 3 12
23. R.J. Steingard, B. Zimnitzky, D.R. DeMaso, M.L. Bauman, and J.P. Bucci Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder J. Child Adolesc. Psychopharmacol. 7 1997 9 15